Therapeutic effect of Buxu Jiedu Huayu Decoction on primary thrombocytosis
Phase 1
Not yet recruiting
- Conditions
- Primary thrombocytosis
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Aged >=18 years old, male and female;
2. Patients who met the above diagnostic criteria;
3. Patients who have no history of allergy to the drugs used in this study and can persist in treatment for at least 3 months.
Exclusion Criteria
(1) Patients with mental illness;
(2) Patients with active hepatitis, venereal disease and other infectious diseases;
(3) Patients with other blood system diseases;
(4) Patients with severe cardiovascular disease, liver and kidney disease;
(5) Pregnant or lactating patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Buxu Jiedu Huayu Decoction's therapeutic effect on primary thrombocytosis?
How does Buxu Jiedu Huayu Decoction compare to standard-of-care treatments for essential thrombocythemia in efficacy and safety?
Are there specific biomarkers that can predict patient response to Buxu Jiedu Huayu Decoction in primary thrombocytosis?
What are the potential adverse events associated with Buxu Jiedu Huayu Decoction in phase I trials for primary thrombocytosis?
What combination therapies or alternative herbal compounds show promise in treating primary thrombocytosis alongside Buxu Jiedu Huayu Decoction?